Genaissance Pharmaceuticals describes link between genetic markers and drug response in cardiovascular disease.

(From Chemical Business NewsBase - Press Release)

Genaissance Pharmaceuticals Inc (Genaissance) presented at the American Heart Association's Scientific Sessions 2003, clinical data describing associations between genetic markers (HAP Markers) and response to treatment with the statin class of drugs. The two presentations provided additional results from Genaissance's Statin Response Examined by Genetic Haplotype Markers ("Strength") clinical study. In one presentation, Genaissance confirmed an association between HAP Markers in the gene apolipoprotein E (ApoE) and levels of C-reactive protein (CRP), which has been associated with inflammation and linked to risk for …